Literature DB >> 10588172

Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome?

D A Drossman1.   

Abstract

Psychological difficulties in patients with irritable bowel syndrome (IBS) are strongly related to symptom severity and patient status. This has important implications for clinical practice, and the design and conduct of clinical trials. Psychosocial factors (personality, psychiatric diagnosis illness behavior, life stress, psychological distress) distinguish patients with IBS from patients with no IBS. Psychosocial difficulties (e.g., history of physical or sexual abuse, maladaptive coping, or "catastrophizing") predict poorer health outcome (greater pain scores, psychologic distress and poorer daily function, more days spent in bed, and more frequent physician visits and surgeries). When using the standardized Functional Bowel Disorder Severity Index, patients classified as severe are distinguished from moderates by several psychosocial difficulties and health-care use variables. In addition, whereas patients with severe illness report more pain, there is no difference from patients with moderate illness in terms of visceral sensation threshold. Given these data, it is important to consider psychosocial factors as predictive of symptom severity and clinical outcome, and this should be considered in clinical care and the design of clinical trials.

Entities:  

Mesh:

Year:  1999        PMID: 10588172     DOI: 10.1016/s0002-9343(99)00081-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  38 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 2.  Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.

Authors:  Fabiane Klem; Akhilesh Wadhwa; Larry J Prokop; Wendy J Sundt; Gianrico Farrugia; Michael Camilleri; Siddharth Singh; Madhusudan Grover
Journal:  Gastroenterology       Date:  2017-01-06       Impact factor: 22.682

Review 3.  Psychosocial determinants of irritable bowel syndrome.

Authors:  Teodora Surdea-Blaga; Adriana Băban; Dan L Dumitrascu
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

4.  Aberrant Salience? Brain Hyperactivation in Response to Pain Onset and Offset in Fibromyalgia.

Authors:  Catherine S Hubbard; Asimina Lazaridou; Christine M Cahalan; Jieun Kim; Robert R Edwards; Vitaly Napadow; Marco L Loggia
Journal:  Arthritis Rheumatol       Date:  2020-05-21       Impact factor: 10.995

Review 5.  Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.

Authors:  Hyo-Rang Lee; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2006-08

6.  Psychologic Therapies for Irritable Bowel Syndrome.

Authors:  Philip Boyce
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

7.  Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert L Burr; Kevin C Cain; Vicky Hertig; Pam Weisman; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Importance of neural mechanisms in colonic mucosal and muscular dysfunction in adult rats following neonatal colonic irritation.

Authors:  A Chaloner; A Rao; E D Al-Chaer; B Greenwood-Van Meerveld
Journal:  Int J Dev Neurosci       Date:  2009-09-17       Impact factor: 2.457

9.  Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome.

Authors:  Y Ringel; W E Whitehead; B B Toner; N E Diamant; Y Hu; H Jia; S I Bangdiwala; D A Drossman
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  Seirogan (wood creosote) inhibits stress-induced ion secretion in rat intestinal epithelium.

Authors:  Koji Ataka; Tomoo Kuge; Kalina Venkova; Beverley Greenwood-Van Meerveld
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.